drugset / Trial / NCT07305844
Impact of Clinician-administered Vaginal Live Biotherapeutic Product
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single-arm, Phase Ib trial assessing the consistency of response and colonization kinetics of a vaginally inserted live biotherapeutic intervention with optimized adherence.
Timeline
- Start
- 2026-04-28
- Primary completion
- 2026-08-13
- Completion
- 2026-08-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LC106 | Other / unclassified | — | Other |